Sobi in PNH –
Our strength lies in rare diseases
At Sobi, we’re developing innovative new medicines to raise standards of care for people with paroxysmal nocturnal haemoglobinuria (PNH).
PNH is a life-threatening rare blood disorder, characterised by haemolytic anaemia, thrombosis and debilitating symptoms.1
Dr Anders Ullman, Chief Medical Officer of Sobi, provides an introduction to PNH
PNH – Unrelieved symptoms
Despite current treatments, people with PNH may still experience debilitating symptoms
The issue of ongoing symptoms with PNH
- Hill A, DeZern AE, Kinoshita T & Brodsky RA. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers 2017;3:17028.
PNH: Paroxysmal nocturnal haemoglobinuria
Job code: PP-17755 | Date of preparation: March 2023
Intended for healthcare professional only